Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CNTNAP3P1 (CNTNAP3 pseudogene 1) is a human pseudogene related to the CNTNAP3 gene (Contactin-associated protein family member 3), but does not encode a functional protein. It is not a functional molecule or receptor, nor is it a recognized therapeutic target. No biological function, disease association, or pharmacological relevance has been attributed to the pseudogene. Structured or functional information refers to its parent gene, CNTNAP3, which is a member of the neurexin family and is involved in cell recognition processes in the nervous system; however, CNTNAP3P1 itself is a non-coding pseudogene. CNTNAP3P1 is a pseudogene, meaning it is a DNA segment similar to a gene but non-functional; it does not produce a functional protein or serve as a drug target. The functional and disease roles associated with CNTNAP3 (not CNTNAP3P1) include implications in neurodevelopmental disorders, but these do not apply to CNTNAP3P1. There are no drugs, biological functions, or safety concerns linked to CNTNAP3P1, and nomenclature or molecular classification systems treat it as a "pseudogene" or "other".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CNTNAP3 pseudogene 1 (CNTNAP3P1).